LIRAVEXIN
XS20
Semax 10 mg + Selank 10 mg
20 mg × 10 vials
1 vialBox of 10
Blends

Semax 10 mg + Selank 10 mg

XS20

Lyophilized peptide for use under a licensed healthcare provider. Choose single ampule/vial or box of 10. Sourced via Ares Technology Limited (Hong Kong) / Healthtide Biotech manufacturing list dated 7 October 2026. Specification: 20 mg × 10 vials.

  • • Prescription / clinician-supervised pathway
  • • Same LIRAVEXIN cart and checkout as pen packages
  • • Not medical advice — individual suitability is determined by your clinician

Clinical reference (clinician-supervised)

What it is used for

Clinic convenience combination reflecting the named components. See individual monographs for each ingredient’s evidence and investigational status. Combination use requires a single supervising clinician plan—never stack duplicate incretins casually.

Typical dose ranges

No unique FDA label for the blend. Dose each active as the clinician would for components (or a written combination protocol). Vial total mg is the sum of labeled actives—not a single ‘peptide dose.’

Frequency

Per clinician protocol (often aligned to the most restrictive component schedule).

Route

Typically subcutaneous after pharmacy preparation under licensed pathway.

Typical clinical / literature ranges under clinician supervision — not a prescription and not a DIY dosing guide. Individual dosing is determined solely by the treating clinician.

Rx / HCP callout: Intended for adult use under supervision of a licensed healthcare provider. This page does not provide medical advice. Liravexin USD prices reflect the wholesale comparison sheet (source × 3).
Cat. No.
XS20
Pack size
Specification
20 mg × 10 vials
$390 USD

Liravexin USD for this pack (wholesale comparison · source × 3). Item is added to your shared cart for checkout coordination with your clinician pathway.

Or continue to checkout →